AINewsnow

Anthropic Reports Early Drug Development Progress With Claude

This story is from 2026-10-27. It is preserved in the archive; the latest stories are on the live feed.

Anthropic on October 27, 2026 published a progress update on its life sciences work, reporting early results from research partnerships with six drug development organizations — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines, and The Column Group — alongsid…

Read the full story at Unite.AI ↗

Timeline · 1 report

  1. 2026-10-27 20:42 · Unite.AI
    Anthropic Reports Early Drug Development Progress With Claude

More stories

  1. Anthropic reveals plans for blockbuster IPO — Sky News Technology
  2. Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy (Anthropic) — Techmeme
  3. Frontier AI labs say their models refuted the Exponential Time Hypothesis. What does that mean? — TechCrunch AI
  4. Anthropic's IPO filing shows soaring sales and steep losses — France 24 — Artificial Intelligence
  5. How Anthropic ships the #1 LLM in the World safely: Separating the Brain from the Hands — Latent Space
  6. Meta announces $95B offering to fund AI — Semafor Technology
  7. Moonshot apologises after Kimi K3.1 Pro roll-out stumbles as promotional scrutiny widens — South China Morning Post Tech
  8. Anthropic's Claude bypassed a paywall to access Georgia voter data without authorization — Axios AI+

Get the daily brief of stories like this at 6:30 every morning →